0001213900-23-100063.txt : 20231229 0001213900-23-100063.hdr.sgml : 20231229 20231229171733 ACCESSION NUMBER: 0001213900-23-100063 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231228 FILED AS OF DATE: 20231229 DATE AS OF CHANGE: 20231229 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SETH SANDESH CENTRAL INDEX KEY: 0001566175 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36374 FILM NUMBER: 231528616 MAIL ADDRESS: STREET 1: 300 E 93RD STREET, #20-B CITY: NEW YORK STATE: NY ZIP: 10128 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Actinium Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001388320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 880378336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 PARK AVE., 23RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: (646) 677-3870 MAIL ADDRESS: STREET 1: 100 PARK AVE., 23RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: Cactus Ventures, Inc. DATE OF NAME CHANGE: 20070130 4 1 ownership.xml X0508 4 2023-12-28 0 0001388320 Actinium Pharmaceuticals, Inc. ATNM 0001566175 SETH SANDESH C/O ACTINIUM PHARMACEUTICALS, INC., 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017 1 1 0 0 Chief Executive Officer 0 Stock Option (Right to Buy) 5.00 2023-12-28 4 A 0 984367 0 A 2033-12-28 Common Stock 984367 984367 D This price represents the closing price of the Issuer's common stock on December 28, 2023, the date of the grant. Pursuant to the terms of the Issuer's 2019 Stock Plan, 2% of the options will vest each month from the date of grant until fully vested. /s/ Sandesh Seth 2023-12-29